title: [Glycemic control in type 2 diabetic patients in public and private healthcare service].
abstract: OBJECTIVE
  To compare the treatment of type 2 diabetic patients from a private clinic with those of a public health service.
  
  
  METHODS
  It was designed a retrospective cohort study, including 80 patients attended at the Central Clinic of Universidade de Caxias do Sul (AMCE), which is related to the Single Health System, and 277 patients attended at a private clinic, whom consult between May 2001 and October 2007.
  
  
  RESULTS
  Patients attended at AMCE showed a worse metabolic control, although only the values of A1c and total cholesterol have reached statistical significance. Both groups had an improvement in almost all the metabolic parameters. The use of insulin at the end of follow-up (B = 4,66; CI95% = 2,18 - 9,89; p < 0,001) and initial A1c (B = 1,42; CI95% = 1,16 - 1,74; p = 0,001) were determinant of a worse glycemic control. The frequency of visits was determinant of a better control (B = 0,72; CI 95% = 0,55 - 0,93; p = 0,01).
  
  
  CONCLUSIONS
  The variables such as the initial A1c and the frequency of visits, which may be considered as indicators of patients' access to the heath system, have greater impact on the control of diabetes than the place where the patients are treated.
authors.affiliation: Faculdade de Medicina, Universidade de Caxias do Sul, Rio Grande do Sul, RS, Brasil. dpanarot@ucs.br
authors.forename: Daniel
authors.initials: D
authors.lastname: Panarotto
authors.forename: Henrique de Araújo Vianna
authors.initials: Hde A
authors.lastname: Träsel
authors.forename: Michele Salibe de
authors.initials: MS
authors.lastname: Oliveira
authors.forename: Lívia Brancher
authors.initials: LB
authors.lastname: Gravina
authors.forename: Alisson Roberto
authors.initials: AR
authors.lastname: Teles
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D001938:Brazil; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004812:Epidemiologic Methods; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006296:Health Services / Q000592:standards / Q000706:statistics & numerical data; D006297:Health Services Accessibility / Q000706:statistics & numerical data; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D018670:Monitoring, Ambulatory; D017063:Outcome Assessment, Health Care; D017149:Private Sector / Q000592:standards / Q000706:statistics & numerical data; D017150:Public Sector / Q000592:standards / Q000706:statistics & numerical data; D012017:Referral and Consultation / Q000706:statistics & numerical data
chemical_list: D001786:Blood Glucose; D002784:Cholesterol; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin